11 Feb 2025
Eicher Motors
BOB Capital Markets Ltd.
Target
5354.00
5079.00
4972.35
(7.68%)
Target met
Hold
Broker Report
Q3 revenue increased ~21%/17% YoY/QoQ to Rs 42.1bn, driven by a mix of volume and realisation gain in the motorcycle segment
11 Feb 2025
Escorts Kubota
BOB Capital Markets Ltd.
Target
3282.70
2533.00
3129.70
(4.89%)
22.84
Sell
Broker Report
Q3 tractors volume rose by 25% YoY (combined volume from JV partners) aided by industry growth, realisation fell 13%
10 Feb 2025
Finolex Industries
BOB Capital Markets Ltd.
Reco
Target
216.46
250.00
195.01
(11.00%)
15.49
Buy
Broker Report
Gained market share in pipe segment in a difficult environment by offering heavy discounts to its dealers
09 Feb 2025
JK Lakshmi Cement
BOB Capital Markets Ltd.
Target
813.15
694.00
843.60
(-3.61%)
Target met
Sell
Broker Report
Double-digit revenue decline YoY by 13% dragged by lower volume growth, down 5%, and weak realisations that fell by 10%
08 Feb 2025
Mahindra & Mahindra
BOB Capital Markets Ltd.
Target
3046.50
3689.00
3198.45
(-4.75%)
21.09
Buy
Broker Report
Automotive and tractor segment volume grew in double digits by ~16% /20% YoY; reflects strong show in festive/post-festive season
08 Feb 2025
The Ramco Cements
BOB Capital Markets Ltd.
Target
987.65
722.00
894.80
(10.38%)
26.90
Sell
Broker Report
Q3 revenue declined ~6%/3% YoY/QoQ as pricing pressures impacted realisations and profitability severely (down by 10%/5% YoY/QoQ)
08 Feb 2025
Life Insurance Corp
BOB Capital Markets Ltd.
Target
953.65
1071.00
816.10
(16.85%)
12.31
Buy
Broker Report
APE and net premium income declined 24% YoY and 11% YoY; renewal premium rose 4% YoY in Q3FY25
08 Feb 2025
Britannia Industries
BOB Capital Markets Ltd.
Reco
Target
5575.50
4395.00
4870.50
(14.47%)
21.17
Sell
Broker Report
Compared to consensus, there was a beat on sales at 1% and on EBITDA at 6%. EBITDA beat on lower SG&A as a % of sales
08 Feb 2025
Firstsource Solutions
BOB Capital Markets Ltd.
380.95
411.00
354.55
(7.45%)
7.89
Buy
Broker Report
3QFY25 broadly in line. Estimate organic growth in FY25 is likely at ~16% CC terms. Possibly second best in the Tierr-2 set
08 Feb 2025
Alkem Laboratories
BOB Capital Markets Ltd.
Reco
Target
4996.50
4527.00
5151.35
(-3.01%)
Target met
Sell
Broker Report
Domestic sales were 6% below our estimates mainly due to slower recovery in the acute therapies and no price hike in NLEM portfolio